Back

Risk factors and prediction model for hypertension in women with hyperandrogenic phenotypes of polycystic ovary syndrome

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Women's cardiovascular disease and pregnancy Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Angelina Stevanovic

Belgrade (Serbia)

6 More presentations in this session

Presentation thumbnail
Risks of antihypertensive treatment use in different periods of pregnancy
Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial
Doctor O. Quesada (Cincinnati, US)
Abstract Slides Video
Presentation thumbnail
Sex differences in trajectory of left ventricular reverse remodelling under contemporary GDMT in recent-onset dilated cardiomyopathy
Doctor Z. Yang (Chengdu - Sichuan, CN)
Abstract Slides Video
Presentation thumbnail
Improving hypertension management in Egyptian women through standardised nurse training on blood pressure measurement
Professor R. Hany Ibrahim (Cairo, EG)
Abstract Slides Video
Presentation thumbnail
Exploring the relationship between testosterone and cardiovascular disease in women
Doctor S. Alexander (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Women's cardiovascular disease and pregnancy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Women with polycystic ovarian syndrome are at increased associated risk of acute myocardial infarction and ischemic stroke
thumbnail
Congress Presentation
Relationship between triglyceride-to-glucose index in addition to waist circumference as a marker of insulin resistance and mean arterial pressure
thumbnail
Congress Presentation
Increased risk of supraventricular tachycardia with polycystic ovarian syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources